Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

In Vitro Antibacterial and Antioxidant Activities, Pharmacokinetics, and In Silico Molecular Docking Study of Phytochemicals from the Roots of Ziziphus Spina-Christi

research In Vitro Antibacterial and Antioxidant Activities, Pharmacokinetics, and In Silico Molecular Docking Study of Phytochemicals from the Roots of Ziziphus spina-christi

January 2024 in “Biochemistry Research International”

Compounds from Ziziphus spina-christi roots show strong antibacterial and antioxidant potential.

research DIABETE E DOLORE: EFFETTO TERAPEUTICO DEI METABOLITI DEL TESTOSTERONE

February 2014 in “Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)”

Testosterone metabolites may help relieve diabetic nerve pain.

ROS-Responsive Hydrogel-Delivered miR-665 Targets STAT3 to Alleviate Inflammation and Promote Hair Follicle Regeneration in Alopecia Areata

research ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata

February 2026 in “Journal of Nanobiotechnology”

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

research Cyclical dermal micro-niche switching governs the morphological infradian rhythm of mouse zigzag hair

4 citations , August 2023 in “Nature Communications”

Mouse zigzag hair bends form due to a 3-day cycle of changes in hair progenitors and their environment.

Real-Time In Vivo Structure-Function Study of Scalp Hair Cycles: An Experimental Approach for Monitoring Living Hair Roots with a 20-Year Follow-Up

research Real-time in vivo structure-function study of scalp hair cycles: an experimental approach for monitoring living hair roots with a 20-year follow-up

February 2025 in “Plastic and Aesthetic Research”

Minoxidil and finasteride effectively promote hair regrowth within 3 months.

Non-Clinical Safety Evaluation and Risk Assessment of Aleglitazar, a Dual PPAR α/γ Agonist, and Its Major Human Metabolite

research Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite

3 citations , March 2017 in “Regulatory toxicology and pharmacology”

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

research Chemotherapy-Induced Alopecia

2 citations , January 2012 in “InTech eBooks”

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Nanofat and PRP vs PRP in Androgenic Alopecia: An Intra-Patient Case-Control Study

research Abstract: Nanofat+Prp Vs Prp in Androgenic Alopecia. An Intra-Patient Case-Control Study

1 citations , September 2018 in “Plastic and reconstructive surgery. Global open”

Combining nanofat with PRP is more effective than PRP alone for treating male hair loss.

research LncRNA-XIST promotes dermal papilla induced hair follicle regeneration by targeting miR-424 to activate hedgehog signaling

11 citations , March 2020 in “Cellular Signalling”

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

research Platelet-Rich Plasma for Hair Restoration

16 citations , March 2020 in “Facial Plastic Surgery Clinics of North America”

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

← Previous page